QUOTE AND NEWS
Benzinga  Oct 13  Comment 
Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company, today announced positive top-line results from a Phase 2a clinical study of LPCN 1111, a novel testosterone replacement therapy ("TRT") candidate, in hypogonadal males. The...
StreetInsider.com  Sep 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/China+Recycling+Energy+%28CREG%29+Unit+to+Sell+TRT+System+in+%245.7M+Deal/9867693.html for the full story.
SeekingAlpha  Sep 23  Comment 
By Jason Napodano, CFA: On September 17th, there was a Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (OTC:DSRM) to examine the appropriate...
StreetInsider.com  Sep 22  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Repros+Therapeutics+%28RPRX%29+Reports+Results+of+FDA+Panel+TRT+Meeting%3B+Population+Not+Suited+to+Androxal/9849970.html for the full story.
SeekingAlpha  Sep 9  Comment 
By David Bautz: On September 17, 2014, the FDA will hold a joint meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss testosterone replacement therapy (TRT)....
Reuters  Aug 12  Comment 
Nine miners were trapped in a Turkish coal mine in the Black Sea province of Zonguldak on Tuesday after part of the structure collapsed, state broadcaster TRT Haber reported.
StreetInsider.com  Feb 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Trio-Tech+International+%28TRT%29+Narrows+Q2+Loss+to+10cShare/9172393.html for the full story.
StreetInsider.com  Nov 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Trio-Tech+International+%28TRT%29+Swings+to+Q1+Profit/8886112.html for the full story.
StreetInsider.com  Sep 27  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Trio-Tech+International+%28TRT%29+Swings+to+Q4+Profit/8726638.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki